GO:0005201 extracellular matrix structural constituent: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005201 (extracellular matrix structural constituent) is a molecular function describing the action of a molecule that contributes to the structural integrity of the extracellular matrix.
• Core matrisome proteins include collagens, elastin, fibrillins, fibronectin, laminins, proteoglycans, and chitin, which together form the architectural scaffold of tissues.
• This function is essential for tissue mechanics, cell signaling, and organ development, and its dysregulation contributes to disc degeneration, lung disease, traumatic brain injury, and cancer.
• Elastin and fibrillin microfibrils provide reversible elasticity to tissues such as skin, lungs, and arteries, and mutations cause connective tissue disorders.
• Decellularized extracellular matrix scaffolds preserve structural constituents and are used in regenerative medicine and tissue engineering.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of ECM structural genes in human disease contexts.
Description
The extracellular matrix (ECM) is a complex, dynamic network of macromolecules that provides structural and biochemical support to surrounding cells. The Gene Ontology molecular function term GO:0005201, extracellular matrix structural constituent, captures the action of molecules that contribute to the structural integrity of this matrix. This function is fundamental to tissue architecture, mechanical properties, and cell-matrix communication across all multicellular organisms. Understanding ECM structural constituents is critical because their dysfunction underlies a broad spectrum of human pathologies, including intervertebral disc degeneration, lung fibrosis, traumatic brain injury, and cancer progression. Research into GO:0005201 has been accelerated by advances in proteomics, imaging, and CRISPR-based genome editing, which allow precise interrogation of individual matrix components.
extracellular matrix structural constituent At A Glance
| GO ID | GO:0005201 |
|---|---|
| GO term | extracellular matrix structural constituent |
| Ontology | molecular_function |
| Synonym | core extracellular matrix; core matrisome; extracellular matrix glycoprotein |
| Major function | Contributes to the structural integrity of the extracellular matrix |
| Representative proteins | Collagens, elastin, fibrillins, fibronectin, laminins, proteoglycans, chitin |
| Associated diseases | Disc degeneration, lung diseases, traumatic brain injury, connective tissue disorders, cancer |
| Research methods | CRISPR knockout/knock-in, proteomics, imaging, decellularized ECM models |
What Is GO:0005201?
GO:0005201, extracellular matrix structural constituent, is defined as the action of a molecule that contributes to the structural integrity of the extracellular matrix. This molecular function is carried out by core matrisome proteins such as collagens, elastin, fibrillins, fibronectin, laminins, and proteoglycans, as well as by chitin in invertebrates. These molecules provide mechanical support, organize matrix architecture, and influence cell behavior through direct interactions with cell surface receptors and other matrix components.
Why Is extracellular matrix structural constituent Important in Cell Biology?
ECM structural constituents are not merely passive scaffolds; they actively regulate cell proliferation, migration, differentiation, and survival through mechanotransduction and signaling. Disruption of these molecules leads to loss of tissue integrity and is a hallmark of numerous diseases, including osteoarthritis, fibrosis, and cancer. Therefore, studying GO:0005201 is essential for understanding tissue homeostasis, repair, and disease pathogenesis, and for developing ECM-targeted therapies.
• Maintains tissue architecture and mechanical properties in cartilage, bone, skin, and blood vessels.
• Regulates cell behavior via integrin-mediated signaling and growth factor sequestration.
• Dysregulation contributes to intervertebral disc degeneration and chronic back pain.
• ECM remodeling is a key feature of traumatic brain injury and neuroinflammation.
• Altered ECM structural constituents are implicated in lung fibrosis and chronic obstructive pulmonary disease.
• Chitin, a structural polysaccharide, is essential for insect cuticle and fungal cell walls, serving as a target for pest control.
• Decellularized ECM scaffolds harness structural constituents for tissue regeneration.
• Mutations in elastin and fibrillin cause connective tissue disorders such as Marfan syndrome and cutis laxa.
• ECM stiffness promotes tumor progression and metastasis.
• CRISPR screens can identify novel ECM structural genes and their regulators.
Molecular Mechanism of extracellular matrix structural constituent
Collagen Fibril Assembly
In simple terms: Collagens are like ropes that twist together to give tissues strength.
Collagens are the most abundant structural proteins in the ECM. They are synthesized as procollagens, secreted, and then processed by proteases to form triple-helical tropocollagen molecules that self-assemble into fibrils and fibers. These fibrils provide tensile strength to skin, bone, tendon, and cartilage. Collagen crosslinking, mediated by lysyl oxidase, further stabilizes the matrix.
Elastin and Microfibril Formation
In simple terms: Elastin is like a rubber band that allows tissues to stretch and recoil.
Elastin is secreted as tropoelastin, which is crosslinked by lysyl oxidase onto a scaffold of fibrillin-rich microfibrils to form elastic fibers. These fibers confer elasticity to lungs, arteries, and skin. Fibrillins also regulate TGF-beta signaling by sequestering latent growth factor complexes.
Proteoglycan and Glycoprotein Networks
In simple terms: Proteoglycans are like hydrated cushions that resist compression.
Proteoglycans, such as aggrecan and decorin, consist of a core protein with glycosaminoglycan side chains. They form large aggregates with hyaluronan, trapping water and providing osmotic resistance to compression in cartilage. Fibronectin and laminins are glycoproteins that mediate cell adhesion and matrix assembly.
Chitin Structure and Function
In simple terms: Chitin is a tough, flexible material found in insect shells and fungal walls.
Chitin is a linear polymer of N-acetylglucosamine that forms crystalline microfibrils, providing structural support in arthropod exoskeletons and fungal cell walls. It is synthesized by chitin synthases and organized into higher-order structures that contribute to mechanical strength and protection.
ECM Remodeling and Turnover
In simple terms: The matrix is constantly being rebuilt and repaired by enzymes.
Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) regulate ECM turnover. Degradation of structural constituents by MMPs is essential for tissue remodeling but becomes pathological in arthritis, cancer, and fibrosis. Crosslinking enzymes and growth factors further modulate matrix stability and cell-matrix interactions.
Key Genes Involved in GO:0005201 extracellular matrix structural constituent
The following genes encode core ECM structural constituents and associated proteins that are central to GO:0005201.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Type I collagen alpha-1 chain; major fibrillar collagen in bone, skin, tendon | Mutations cause osteogenesis imperfecta; target in fibrosis and cancer |
| COL1A2 | Type I collagen alpha-2 chain; forms heterotrimeric collagen I | Associated with connective tissue disorders and bone fragility |
| COL2A1 | Type II collagen; primary collagen in cartilage | Mutations linked to chondrodysplasias and osteoarthritis |
| COL4A1 | Type IV collagen; basement membrane network | Implicated in vascular and renal diseases |
| ELN | Elastin; provides elasticity to tissues | Mutations cause cutis laxa and supravalvular aortic stenosis |
| FBN1 | Fibrillin-1; microfibril scaffold and TGF-beta regulator | Mutations cause Marfan syndrome |
| FN1 | Fibronectin; cell adhesion and matrix assembly | Involved in wound healing and cancer metastasis |
| LAMA1 | Laminin subunit alpha-1; basement membrane component | Roles in development and cancer |
| LAMB1 | Laminin subunit beta-1; basement membrane assembly | Associated with muscular dystrophy and cancer |
| ACAN | Aggrecan; major cartilage proteoglycan | Mutations cause skeletal dysplasias; target in osteoarthritis |
| DCN | Decorin; small leucine-rich proteoglycan | Regulates collagen fibrillogenesis and TGF-beta |
| HSPG2 | Perlecan; basement membrane heparan sulfate proteoglycan | Roles in development and cancer |
| CHS1 | Chitin synthase; synthesizes chitin in fungi and insects | Target for antifungal and insecticidal strategies |
| LOX | Lysyl oxidase; crosslinks collagen and elastin | Implicated in fibrosis and cancer |
| MMP2 | Matrix metalloproteinase-2; degrades ECM components | Associated with cancer invasion and arthritis |
| TIMP1 | Tissue inhibitor of metalloproteinases-1; regulates MMP activity | Biomarker in fibrosis and cancer |
| SPARC | Secreted protein acidic and cysteine-rich; collagen binding | Roles in bone and tumor stroma |
| TNC | Tenascin-C; matricellular protein | Involved in inflammation and cancer |
How Is extracellular matrix structural constituent Regulated?
The expression and activity of ECM structural constituents are regulated at multiple levels. Transcription factors such as TGF-beta/SMAD and Wnt signaling pathways control ECM gene expression. Post-translational modifications, including hydroxylation, glycosylation, and crosslinking, determine matrix stability and function. Proteolytic processing by MMPs and ADAMTS proteases regulates turnover and remodeling. In disease, dysregulated TGF-beta signaling alters ECM composition in fibrosis and cancer. Additionally, mechanical forces from the cellular microenvironment feedback to modulate ECM gene expression through mechanotransduction pathways.
extracellular matrix structural constituent and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COL2A1 | Osteoarthritis and chondrodysplasia | Knockout mouse chondrocytes; point mutation knock-in |
| ELN | Cutis laxa and aortic stenosis | Elastin knockout mouse; overexpression in fibroblasts |
| FBN1 | Marfan syndrome | Fbn1 knock-in mouse; CRISPR point mutation in iPSCs |
| ACAN | Intervertebral disc degeneration | Aggrecan knockout in disc cells; overexpression in mesenchymal stem cells |
| MMP2 | Cancer invasion and fibrosis | MMP2 knockout in cancer cell lines; CRISPR knockout in organoids |
Intervertebral Disc Degeneration
The intervertebral disc relies on ECM structural constituents, particularly aggrecan and collagen II, to maintain hydration and mechanical function. Degeneration involves loss of proteoglycans, increased collagen I, and elevated MMP activity, leading to disc height loss and back pain. Targeting ECM structural genes may offer therapeutic strategies.
Lung Diseases
In pulmonary fibrosis, excessive deposition of collagen and fibronectin stiffens lung tissue and impairs gas exchange. Elastin degradation contributes to emphysema in COPD. ECM structural constituents are therefore key biomarkers and therapeutic targets in chronic lung diseases.
Traumatic Brain Injury
After traumatic brain injury, ECM remodeling occurs, with upregulation of chondroitin sulfate proteoglycans and tenascin-C that inhibit axon regeneration. Modulating ECM structural constituents may promote neural repair.
Cancer
Tumor stroma is enriched in ECM structural proteins such as collagen I, fibronectin, and tenascin-C, which promote proliferation, invasion, and metastasis. High matrix stiffness activates mechanotransduction pathways that drive malignancy. Targeting ECM structural constituents is an emerging anticancer strategy.
From extracellular matrix structural constituent-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of COL1A1 affect matrix stiffness? | CRISPR knockout in human fibroblasts |
| Does a specific point mutation in ELN alter elastic fiber assembly? | Point mutation knock-in in iPSCs |
| Can overexpression of FN1 rescue matrix assembly in disease cells? | Overexpression in patient-derived fibroblasts |
| What is the role of ACAN in disc degeneration? | Knockout in nucleus pulposus cells; overexpression in stem cells |
| How does FBN1 mutation affect TGF-beta signaling? | Knock-in mouse model; CRISPR-edited organoids |
| Can decellularized ECM from edited cells support regeneration? | Decellularized ECM scaffolds from CRISPR-edited cells |
How to Study the extracellular matrix structural constituent Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry proteomics | ECM protein composition and modifications | Identification of matrisome components in tissues |
| Immunofluorescence microscopy | Localization of collagen, elastin, fibronectin | Visualizing matrix architecture in cells and tissues |
| Atomic force microscopy | Matrix stiffness and elasticity | Mechanical characterization of ECM |
| CRISPR knockout screens | Gene function in matrix assembly | Discovery of novel ECM regulators |
| RNA-seq | Transcriptional profiling of ECM genes | Expression changes in disease models |
| Decellularized ECM assays | Cell adhesion, proliferation, differentiation | Tissue engineering and regeneration |
| Western blot | Protein levels of ECM constituents | Validation of knockout or overexpression |
| Hydroxyproline assay | Collagen content | Quantification of collagen synthesis |
Proteomics and Mass Spectrometry
Mass spectrometry-based proteomics enables comprehensive identification and quantification of ECM structural constituents in tissues and cell cultures. It can detect post-translational modifications such as hydroxylation and crosslinking that are critical for matrix function.
Imaging and Mechanical Testing
Confocal and electron microscopy visualize collagen fibrils, elastin fibers, and proteoglycan networks. Atomic force microscopy and tensile testing quantify matrix stiffness and elasticity, linking structural changes to mechanical properties.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes that regulate ECM structural constituent expression or matrix assembly. Pooled screens with ECM-specific readouts, such as collagen deposition or stiffness, reveal novel regulators.
Decellularized ECM Models
Decellularized ECM scaffolds preserve native matrix architecture and composition, providing physiologically relevant platforms to study cell-matrix interactions and tissue regeneration. These models can be combined with CRISPR editing to test the role of specific structural constituents.
How CRISPR Can Be Used to Study GO:0005201 extracellular matrix structural constituent
Knockout
CRISPR knockout of ECM structural genes, such as COL1A1 or ELN, allows researchers to study loss-of-function phenotypes in matrix assembly, cell behavior, and disease models. Knockout cell lines and animal models reveal essential roles in tissue integrity.
Point Mutation
Point mutation knock-in via CRISPR can model disease-causing mutations, such as those in FBN1 for Marfan syndrome or COL2A1 for chondrodysplasia, enabling precise genotype-phenotype studies.
Knock-in
Knock-in of tagged ECM proteins, such as GFP-tagged collagen or elastin, facilitates live-cell imaging and protein tracking without altering function. This approach is valuable for studying matrix assembly dynamics.
Overexpression
CRISPR activation or cDNA overexpression of ECM structural genes, such as FN1 or ACAN, can rescue matrix defects or enhance regeneration in disease models. Overexpression models help identify sufficiency in matrix formation.
How EDITGENE Supports extracellular matrix structural constituent Research
Researchers studying extracellular matrix structural constituent-related genes often need to determine whether a candidate gene is causally involved in matrix assembly, tissue integrity, or disease progression. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for extracellular matrix structural constituent research.
Frequently Asked Questions About extracellular matrix structural constituent
What is GO:0005201 extracellular matrix structural constituent?
GO:0005201 is a Gene Ontology molecular function term describing the action of a molecule that contributes to the structural integrity of the extracellular matrix.
What genes are involved in extracellular matrix structural constituent?
Key genes include COL1A1, COL1A2, COL2A1, ELN, FBN1, FN1, LAMA1, LAMB1, ACAN, DCN, and HSPG2, among others.
What diseases are associated with ECM structural constituents?
They are linked to intervertebral disc degeneration, lung fibrosis, traumatic brain injury, connective tissue disorders, and cancer.
How can I study extracellular matrix structural constituents?
Common methods include proteomics, imaging, mechanical testing, and CRISPR-based knockout or knock-in models.
What is the role of elastin in the ECM?
Elastin provides elasticity to tissues such as skin, lungs, and arteries, and is assembled into elastic fibers with fibrillin microfibrils.
How does chitin relate to ECM structural constituents?
Chitin is a structural polysaccharide in insect exoskeletons and fungal cell walls, providing mechanical support.
Can CRISPR be used to model ECM-related diseases?
Yes, CRISPR knockout, point mutation knock-in, and overexpression models are widely used to study ECM gene function and disease mechanisms.
What is the core matrisome?
The core matrisome refers to the set of ECM structural proteins, including collagens, proteoglycans, and glycoproteins, that form the matrix scaffold.
How does ECM stiffness affect cancer?
Increased ECM stiffness promotes tumor progression, invasion, and metastasis through mechanotransduction pathways.
What are decellularized ECM models?
Decellularized ECM scaffolds are derived from tissues or cell cultures, preserving native matrix structure for regenerative medicine and ECM research.
Conclusion
GO:0005201 extracellular matrix structural constituent defines a fundamental molecular function that underpins tissue architecture and homeostasis. Its dysregulation is central to many human diseases, making it a critical area of research. Advances in CRISPR genome editing and ECM modeling provide powerful tools to dissect the roles of individual structural constituents and develop targeted therapies.
References
- 1. Karamanos NK et al.. 2021. A guide to the composition and functions of the extracellular matrix.. FEBS J 288(24):6850-6912 PMID: 33605520
- 2. Vindin H et al.. 2019. Elastin architecture.. Matrix Biol 84:4-16 PMID: 31301399
- 3. Raj PP. 2008. Intervertebral disc: anatomy-physiology-pathophysiology-treatment.. Pain Pract 8(1):18-44 PMID: 18211591
- 4. George N et al.. 2018. Extracellular matrix and traumatic brain injury.. J Neurosci Res 96(4):573-588 PMID: 29344975
- 5. Feng H et al.. 2006. Extracellular matrix in disc degeneration.. J Bone Joint Surg Am 88 Suppl 2:25-9 PMID: 16595439
- 6. Tanino Y. 2024. Roles of extracellular matrix in lung diseases.. Fukushima J Med Sci 70(1):1-9 PMID: 38267030
- 7. Moussian B. 2019. Chitin: Structure, Chemistry and Biology.. Adv Exp Med Biol 1142:5-18 PMID: 31102240
- 8. Liu C et al.. 2022. Decellularized extracellular matrix mediates tissue construction and regeneration.. Front Med 16(1):56-82 PMID: 34962624
